Apricus Biosciences, Inc. announced top-line results from the Phase IIb proof-of-concept study of fispemifene in men with secondary hypogonadism and...
Containing relevant Learning Zones, guidelines, trials and news.
A rapid increase in awareness of androgen deficiency has led to substantial increases in prescribing of testosterone therapy (TTh), with benefits of improvements in mood, libido, bone density, muscle mass, body composition, energy, and cognition.
Pycnogenol extract from Horpagh Research Ltd, can ease Menopause and digestive problems according to a recent study. Seventy peri-menopausal randomly...
Just over a third of postmenopausal women who are treated for estrogen-sensitive Breast Cancer using drugs such as Arimidex (anastrozole),...
AMAG Pharmaceuticals, Inc. announced that the FDA has accepted its New Drug Application (NDA) for bremelanotide, a first-in-class melanocortin 4...
Acamprosate is indicated as therapy to maintain abstinence in alcohol-dependent patients. It should be combined with counselling.
Pramipexole is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson's disease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “on off” fluctuations). Pramipexole is indicated in adults for symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in doses up to 0.54 mg of base (0.75 mg of salt) (see section 4.2).